0. Advocacy Webpage Graphics-Narrow-Cover It

One of the greatest barriers to the successful treatment of individuals with addiction is the current healthcare financing system for much of addiction treatment, which offers little support for the coordination of behavioral, social, and psychological services that patients often need in addition to medication. ASAM identifies and advocates for policies and practices that ensure equitable access to comprehensive high-quality addiction prevention, treatment, remission and recovery for all.




1_Cover

Learn how ASAM is leading the national movement to increase access to and improve the quality of evidence-based addiction treatment.




Featured Public Policy Statements

1. bup c

Patient Review and Restriction (PRR) Programs

Learn ASAM's position on Patient Review and Restriction (PRR) or pharmacy "lock-in" programs.

medical-specialist-FI b

Inclusion of Addiction Specialist Physicians in Managed Behavioral Health Care Organization In-Network Provider Panels

Managed behavioral health care organizations should accept non-psychiatrist physicians who are addiction treatment specialists on their provider panels.





"The current physician reimbursement structure does not account for all the services that patients with an opioid use disorder need to progress to successful treatment and recovery."

-Shawn Ryan, MD, MBA, ABEM, ABAM, FASAM
Member of ASAM's Payer Relations Committee




Resources

Documents

Section 1115 Waivers

Learn how states are using Section 1115 Waivers to waive federal requirements that cannot be waived by a State Plan Amendment.
Billing & Coding

Billing & Coding

Access information on the language of reimbursement for addiction treatment services.

Parity

See what ASAM is doing to increase insurance coverage for addiction treatment.



Related News

newspapers-3488857_1920B
  • July 23, 2019

    ASAM Board Member Testifies Before Congressional Opioid Task Force

    Dr. Margaret Jarvis, Board Member of ASAM, participated in a congressional roundtable sponsored by the House Bipartisan Heroin and Opioid Task Force. At the event, Dr. Jarvis discussed the need for greater financial investment in demand-reduction interventions and emphasized the need for bold policy solutions to meet the scale of the opioid crisis.
  • May 9, 2019

    ASAM Praises Funding for Critical SUD Workforce Programs in FY 2020 House Labor-HHS Appropriations Bill

    ASAM praised the House Appropriations Committee for including full funding for two new critical substance use disorder (SUD) workforce programs in its FY 2020 Labor, Health and Human Services (HHS), Education, and Related Agencies appropriations bill.
  • May 8, 2019

    ASAM Applauds Introduction of Comprehensive Addiction Resources Emergency (CARE) Act of 2019

    ASAM commended Senator Elizabeth Warren, Representatives Elijah Cummings, and all original co-sponsors for introducing the CARE Act of 2019. Modeled on successful, bipartisan legislation passed in 1990 to address the HIV/AIDS epidemic, the CARE Act would authorize $100 billion in federal funding over the next decade to states, local governments, and other organizations and institutions to support substance use disorder treatment programs, improve training for addiction treatment professionals in communities across the US, and expand access to treatments that meet national standards and are proven to save lives.